IP Library Granted Patent US 8,718,949
Granted Patent B2
US 8,718,949 · App. 13/481,302 · Granted May 6, 2014

Insulin pump with blood glucose modules

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,718,949
App. No.
13/481,302
Granted
May 6, 2014
Kind
B2
Abstract

An apparatus comprising a pump, an input configured to receive information related to a user, a user interface, and a controller communicatively coupled to the pump, the input, and the user interface. The controller includes a timing module configured to initiate delivery of a drug in time and to adjust delivery according to the received information. Other devices, systems, and methods are disclosed.

Claims (15)

1. An apparatus comprising:

an input configured to receive blood glucose data, wherein the blood glucose data is obtained during a number of specified blood glucose testing times;

to user interface; and

a controller commicatively coupled to the input, and the user interface, wherein the controller includes:

blood glucose data module configured to calculate statistical measure of blood glucose variability of the user from the blood glucose data, and wherein the controller is configured to automatically adjust a blood glucose testing time from a previously stored testing time in response to the measure of blood glucose variability.

2. The apparatus of claim 1 , wherein the controller includes:

a comparison module configured to compare the calculated measure of blood glucose variability to a threshold blood glucose variability value, and wherein the controller is configured to increase the number of blood glucose testing times if the measure of blood glucose variability exceeds a blood glucose variability target value by more than a first threshold blood glucose variability value, and decrease the number of blood glucose testing times if the measure of blood glucose variability is less than the blood glucose variability target value by more than a second threshold blood glucose variability value.

3. The apparatus of claim 1 , including a memory communicatively coupled to the controller to store an indication of a user preference for a blood glucose testing time, and wherein the controller is configured to adjust the blood glucose testing time according to the indication.

4. The apparatus of claim 3 , wherein the controller is configured to schedule a plurality of blood glucose testing times according to the indication.

5. The apparatus of claim 1 , including a blood glucose monitor communicatively coupled to the input and configured to test blood glucose in response to a prompt received from the controller.

6. The apparatus of claim 1 , including a communication port coupled to the input and configured to receive blood glucose data from a device separate from the blood glucose management device, and wherein the controller is configured to communicate an adjusted blood glucose testing time to the separate device.

7. The apparatus of claim 1 , wherein the user interface includes a display, wherein the controller is configured to prompt a user, via the display, to test blood glucose at an adjusted time using a separate device.

8. The apparatus of claim 7 , wherein the user interface is configured to receive manual entry of the blood glucose data from the user.

9. The apparatus of claim 1 , including:

a pump communicatively coupled to the controller and configured to deliver insulin, and wherein the controller is configured to adjust the blood glucose testing time in response to the measure of blood glucose variability and according to times of insulin delivery.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2024
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: TANDEM DIABETES CARE, INC.
Reel/Frame 066880/0918 →
SECURITY INTEREST Recorded May 25, 2022
From: TANDEM DIABETES CARE, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 060179/0100 →
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2018
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II L.P. - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.
To: TANDEM DIABETES CARE, INC.
Reel/Frame 046761/0843 →
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2018
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II L.P. - PARALLEL FUND "A" L.P.
To: TANDEM DIABETES CARE, INC.
Reel/Frame 046763/0268 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Apr 4, 2014
From: TANDEM DIABETES CARE, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.
Reel/Frame 032608/0780 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Dec 26, 2012
From: TANDEM DIABETES CARE, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.
Reel/Frame 029529/0886 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2012
From: SMITHS MEDICAL ASD, INC.
To: TANDEM DIABETES CARE, INC.
Reel/Frame 029121/0430 →
MERGER Recorded Jul 31, 2012
From: SMITHS MEDICAL MD, INC.
To: SMITHS MEDICAL ASD, INC.
Reel/Frame 028689/0474 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2012
From: BLOMQUIST, MICHAEL; KOPP, KEVIN; SAVARD, THOMAS A.
To: SMITHS MEDICAL MD, INC.
Reel/Frame 028687/0279 →